Vaccinex (VCNX) News Today → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free VCNX Stock Alerts $7.50 -0.05 (-0.66%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Vaccinex, Inc. (NASDAQ:VCNX) Declines By 40.5%americanbankingnews.com - March 28 at 1:54 AMVaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rulesglobenewswire.com - March 27 at 8:30 AMVaccinex CFO Scott Royer to retire, Jill Sanchez steps ininvesting.com - March 6 at 7:15 PMVaccinex Inc VCNXmorningstar.com - March 2 at 3:46 PMVaccinex, Inc.: Vaccinex Announces Multiple New Agreements for Access to ActivMAb Antigen Virus Technologyfinanznachrichten.de - February 21 at 9:42 AMVaccinex Enters Antibody Discovery Agreements Incorporating ActivMAb Drug Discovery Platformmarkets.businessinsider.com - February 21 at 9:42 AMVaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technologyfinance.yahoo.com - February 21 at 9:42 AMVaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technologyglobenewswire.com - February 21 at 8:00 AMmarketbeat.com - February 19 at 6:09 AMVaccinex Announces 1-For-14 Reverse Stock Splitmarkets.businessinsider.com - February 15 at 4:28 PMWhy Vaccinex (VCNX) Stock Is Trading Lowermsn.com - February 15 at 4:28 PMVaccinex, Inc. Announces Reverse Stock Splitglobenewswire.com - February 15 at 8:00 AMSteven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex Incfinance.yahoo.com - February 12 at 2:49 PMVaccinex Inc Secures $3.7M in Private Placement Dealmsn.com - February 8 at 10:26 AMWhy Vaccinex (VCNX) Stock Is Popping Offmsn.com - February 7 at 2:45 PMVaccinex Announces Pricing of $3.7 Million PIPE Financingmarkets.businessinsider.com - February 7 at 9:45 AMNasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rulefinance.yahoo.com - December 4 at 8:50 AMVaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 13 at 9:59 AMVaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meetingfinance.yahoo.com - October 31 at 11:18 AMVaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseasesfinance.yahoo.com - October 26 at 9:40 AMWhy Is Vaccinex (VCNX) Stock Up 26% Today?markets.businessinsider.com - October 6 at 8:58 AMVaccinex, Inc.: Vaccinex Announces Pricing of $9.6 Million Public Offeringfinanznachrichten.de - September 29 at 11:01 PMVaccinex Shares Slide Premarket After Stock Offeringmarketwatch.com - September 29 at 12:59 PMVaccinex Announces Pricing of $9.6 Million Public Offeringfinance.yahoo.com - September 29 at 1:06 AMVaccinex's Next Generation ActivMAb® Technology Published in mAbs, a Leading Biotech Journal, and Validated in OmniAb Proof-of-Concept Collaborationstockhouse.com - September 28 at 3:04 PMVaccinex’s Next Generation ActivMAb® Technology Published in mAbs, a Leading Biotech Journal, and Validated in OmniAb Proof-of-Concept Collaborationfinance.yahoo.com - September 28 at 10:04 AMVaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Applicationfinance.yahoo.com - September 27 at 8:15 AMVaccinex Recent Insider Activitybenzinga.com - September 26 at 2:53 PMVaccinex Board to Implement 1-for-15 Reverse Stock Splitmarketwatch.com - September 22 at 4:59 PMVaccinex, Inc. Announces Reverse Stock Splitfinance.yahoo.com - September 22 at 4:59 PMVaccinex Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 6:52 PMVaccinex, Inc. to Participate in the Jefferies Healthcare Conference Track 6, on Friday, June 9, 2023 at 10:00 to 10:25 a.m. ETfinance.yahoo.com - June 1 at 12:39 PMVaccinex Stock (NASDAQ:VCNX), Dividendsbenzinga.com - May 31 at 1:22 AMVaccinex GAAP EPS of -$0.10, revenue of $0.55Mseekingalpha.com - May 17 at 1:12 PMVaccinex, Inc.: Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 16 at 9:03 AMVaccinex Completes Enrollment in Phase 1b/2 SIGNAL-AD (Alzheimer’s Disease) Study of Pepinemabfinance.yahoo.com - April 25 at 10:11 AMVaccinex New ActivMAb® application published in Nature Communications for Directed Evolution of GPCRs in Mammalian Cellsfinance.yahoo.com - April 12 at 9:57 AMVaccinex Announces Private Placement with Commitments of $5.0 Millionfinance.yahoo.com - April 3 at 1:11 PMVaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programsfinance.yahoo.com - April 3 at 8:10 AMVaccinex, Inc. to Present at the 2023 AAIC Advancements: Immunity Conferencefinance.yahoo.com - March 23 at 10:47 AMVaccinex Announces Initiation of Single-Arm Open Label, Phase Ib/2 Study to Evaluate Pepinemab in Combination with Avelumab as Second Line Combination Immunotherapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)finance.yahoo.com - March 21 at 10:18 AMVaccinex Reports that KEYNOTE B-84 has Reached Targeted Enrollment for Pre-planned Interim Analysisfinance.yahoo.com - March 9 at 8:44 AMMarketBeat Week in Review – 2/6 - 2/10 (VCNX)marketbeat.com - February 11 at 3:24 PMShould Investors Buy or Sell the Vaccinex Patent News?marketbeat.com - February 7 at 11:09 AMVaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncologyfinance.yahoo.com - January 9 at 8:29 AMVaccinex, Inc. (VCNX) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - December 31 at 1:08 PMVaccinex Announces $3.8 Million Private Placementfinance.yahoo.com - November 28 at 4:52 PMVaccinex Third Quarter 2022 Earnings: US$0.11 loss per share (vs US$0.17 loss in 3Q 2021)finance.yahoo.com - November 16 at 6:33 AMVaccinex and its Collaborators Present Two Abstracts Related to Pepinemab Combination Immunotherapy Trials at 37th Annual Meeting of Society for Immunotherapy of Cancerfinance.yahoo.com - November 10 at 4:40 PMCompanies Like Vaccinex (NASDAQ:VCNX) Could Be Quite Riskyfinance.yahoo.com - November 3 at 8:52 AM Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address CBOE shift unlocks new weekend income strategy (Ad)You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! VCNX Media Mentions By Week VCNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCNX News Sentiment▼0.960.61▲Average Medical News Sentiment VCNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCNX Articles This Week▼30▲VCNX Articles Average Week Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AIMD News Today ALZN News Today KTTA News Today CANF News Today IMNN News Today SHPH News Today HILS News Today CLVR News Today VIRI News Today ATHE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCNX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.